Invivyd, Inc. (IVVD)
0.6636
+0.06
(+9.18%)
USD |
NASDAQ |
Oct 15, 16:00
0.679
+0.02
(+2.32%)
After-Hours: 20:00
Invivyd Market Cap : 195.60M for Oct. 15, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 14, 2026 | 179.15M |
| October 13, 2026 | 190.41M |
| October 12, 2026 | 198.46M |
| October 09, 2026 | 212.58M |
| October 08, 2026 | 206.45M |
| October 07, 2026 | 214.76M |
| October 06, 2026 | 237.69M |
| October 05, 2026 | 247.36M |
| October 02, 2026 | 242.32M |
| October 01, 2026 | 240.67M |
| September 30, 2026 | 256.47M |
| September 29, 2026 | 250.57M |
| September 28, 2026 | 280.02M |
| September 25, 2026 | 275.36M |
| September 24, 2026 | 269.20M |
| September 23, 2026 | 272.09M |
| September 22, 2026 | 284.14M |
| September 21, 2026 | 300.65M |
| September 18, 2026 | 222.63M |
| September 17, 2026 | 219.95M |
| September 16, 2026 | 237.37M |
| September 15, 2026 | 244.65M |
| September 14, 2026 | 262.86M |
| September 11, 2026 | 231.53M |
| September 10, 2026 | 228.70M |
| Date | Value |
|---|---|
| September 09, 2026 | 235.01M |
| September 08, 2026 | 243.41M |
| September 04, 2026 | 243.47M |
| September 03, 2026 | 246.12M |
| September 02, 2026 | 236.98M |
| September 01, 2026 | 259.36M |
| August 31, 2026 | 281.46M |
| August 28, 2026 | 284.29M |
| August 27, 2026 | 265.31M |
| August 26, 2026 | 265.78M |
| August 25, 2026 | 276.69M |
| August 24, 2026 | 277.81M |
| August 21, 2026 | 293.72M |
| August 20, 2026 | 280.25M |
| August 19, 2026 | 282.82M |
| August 18, 2026 | 255.88M |
| August 17, 2026 | 218.27M |
| August 14, 2026 | 212.49M |
| August 13, 2026 | 202.11M |
| August 12, 2026 | 215.76M |
| August 11, 2026 | 202.64M |
| August 10, 2026 | 190.36M |
| August 07, 2026 | 209.27M |
| August 06, 2026 | 186.37M |
| August 05, 2026 | 170.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 285.10M |
| Amgen, Inc. | 234.63B |
| Anika Therapeutics, Inc. | 277.16M |
| BioCryst Pharmaceuticals, Inc. | 2.046B |
| Imunon, Inc. | 4.899M |
Market Cap Related Metrics
| PS Ratio | 3.076 |
| Price to Book Value | 1.080 |
| Price | 0.6636 |
| Earnings Yield | -56.21% |